Comprehensive Cancer Institute

Huntsville, Alabama 35801

0 studies enrolling now · 17 studies all time

What they study most

Breast Cancer, Cachexia, Carcinoma of Unknown Primary, Colonic Neoplasms, Colorectal Neoplasms, Fallopian Tube Cancer, Lung Cancer, Lymphoma, Lymphoproliferative Disorder, Metastatic Breast Cancer, Myelodysplastic Syndrome (MDS), Non-small-cell Lung Carcinoma

Studies at this site

• Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes — Completed
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer — Completed
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 — Completed
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
• Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer — Completed
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed
• A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer — Completed
• Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) — Stopped early
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
• Clinical Trial for Ovarian Cancer (OvaRex®) — Stopped early
• Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma — Stopped early
• Protocol for Radiofrequency Ablation of Pulmonary Neoplasms — Stopped early